325 related articles for article (PubMed ID: 15902848)
1. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
[TBL] [Abstract][Full Text] [Related]
2. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Blann AD; Tan KT; Tayebjee MH; Davagnanam I; Moss M; Lip GY
Thromb Haemost; 2005 Mar; 93(3):578-83. PubMed ID: 15735813
[TBL] [Abstract][Full Text] [Related]
4. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
5. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
[TBL] [Abstract][Full Text] [Related]
7. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Choudhury A; Chung I; Blann AD; Lip GYH
Chest; 2007 Mar; 131(3):809-815. PubMed ID: 17356097
[TBL] [Abstract][Full Text] [Related]
8. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests.
Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M
Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472
[TBL] [Abstract][Full Text] [Related]
10. Course of platelet activation markers after ischemic stroke.
Marquardt L; Ruf A; Mansmann U; Winter R; Schuler M; Buggle F; Mayer H; Grau AJ
Stroke; 2002 Nov; 33(11):2570-4. PubMed ID: 12411644
[TBL] [Abstract][Full Text] [Related]
11. Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
Tan KT; Tayebjee MH; Macfadyen RJ; Lip GY; Blann AD
Platelets; 2005 Sep; 16(6):368-71. PubMed ID: 16194867
[TBL] [Abstract][Full Text] [Related]
12. Increased platelet aggregation and activation in peripheral arterial disease.
Robless PA; Okonko D; Lintott P; Mansfield AO; Mikhailidis DP; Stansby GP
Eur J Vasc Endovasc Surg; 2003 Jan; 25(1):16-22. PubMed ID: 12525806
[TBL] [Abstract][Full Text] [Related]
13. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
14. Activation of circulating platelets in patients with peripheral arterial disease during digital subtraction angiography and percutaneous transluminal angioplasty.
Buchholz AM; Bruch L; Schulte KL
Thromb Res; 2003 Jan; 109(1):13-22. PubMed ID: 12679127
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients.
Csongrádi É; Nagy B; Fulop T; Varga Z; Karányi Z; Magyar MT; Oláh L; Papp M; Facskó A; Kappelmayer J; Paragh G; Káplár M
Thromb Haemost; 2011 Oct; 106(4):683-92. PubMed ID: 21866298
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation markers and the primary antiphospholipid syndrome (PAPS).
Joseph JE; Harrison P; Mackie IJ; Machin SJ
Lupus; 1998; 7 Suppl 2():S48-51. PubMed ID: 9814673
[TBL] [Abstract][Full Text] [Related]
17. Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy.
Omoto S; Nomura S; Shouzu A; Hayakawa T; Shimizu H; Miyake Y; Yonemoto T; Nishikawa M; Fukuhara S; Inada M
Nephron; 1999; 81(3):271-7. PubMed ID: 10050080
[TBL] [Abstract][Full Text] [Related]
18. PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS).
Kolarov P; Tschoepe D; Nieuwenhuis HK; Gries FA; Strauer B; Schultheiss HP
Eur Heart J; 1996 Aug; 17(8):1216-22. PubMed ID: 8869863
[TBL] [Abstract][Full Text] [Related]
19. Perioperative platelet and monocyte activation in patients with critical limb ischemia.
Burdess A; Nimmo AF; Campbell N; Harding SA; Garden OJ; Dawson AR; Newby DE
J Vasc Surg; 2010 Sep; 52(3):697-703. PubMed ID: 20816321
[TBL] [Abstract][Full Text] [Related]
20. Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thickness.
Csongrádi É; Káplár M; Nagy B; Koch CA; Juhász A; Bajnok L; Varga Z; Seres I; Karányi Z; Magyar MT; Oláh L; Facskó A; Kappelmayer J; Paragh G
Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):571-580. PubMed ID: 28428025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
